Association between kidney and cardiac diastolic function in Chinese subjects without overt disease: Correlation with ageing and inflammatory markers

European Journal of Clinical Investigation

Volumn 41, Issue 10, 2011, Pages 1077-1086

  Han, Lu Lu ^a   Bai, Xiao Juan ^a   Lin, Hong Li ^b   Sun, Xue Feng ^c   Chen, Xiang Mei ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cardiac diastolic function; Cross sectional study; Cystatin C; Glomerular filtration rate

Indexed keywords

CHOLESTEROL; CREATININE; CYSTATIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN; TRIACYLGLYCEROL; UREA;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DIASTOLE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ENZYME INACTIVATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FILLING; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COHORT STUDIES; CYSTATIN C; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 80052624291     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02503.x     Document Type: Article

References (29)

1. Martin JE, Sheaff MT. Renal ageing. J Pathol 2007;211:198-205.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
4. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003;107:139-46.
5. Schrier RW. Cardiorenal versus renocardiac syndrome: is there a difference? Nat Clin Pract Nephrol 2007;3:637.
6. Ronco C, House AA, Haapio M. Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus. Nat Clin Pract Nephrol 2008;4:310-1.
7. Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008;36(1 Suppl):S75-88.
8. Grupo de Trabajo para el Tratamiento de la Hipertensión Arterial de la Sociedad Europea; Sociedad Europea de Cardiología, Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R et al. ESH/ESC 2007 Guidelines for the management of arterial hypertension. Rev Esp Cardiol 2007;60:968.e1-94.
9. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006;145:237-46.
10. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004;44:198-206.
11. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, Garg M et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-200.
12. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-62.
13. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
14. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15.
15. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002;13:745-53.
16. Han L, Bai X, Lin H, Sun X, Chen XM. Lack of independent relationship between age-related kidney function decline and carotid intima-media thickness in a healthy Chinese population. Nephrol Dial Transplant 2010;25:1859-65.
17. Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenck H et al. The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 1998;36:175-8.
18. Uzun H, Ozmen Keles M, Ataman R, Aydin S, Kalender B, Uslu E et al. Serum cystatin C level as a potentially good marker for impaired kidney function. Clin Biochem 2005;38:792-8.
19. Inney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000;37:49-59.
20. Kitzman DW, Sheikh KH, Beere PA, Philips JL, Higginbotham MB. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 1991;18:1243-50.
21. Gardin JM, Arnold AM, Bild DE, Smith VE, Lima JA, Klopfenstein HS et al. Left ventricular diastolic filling in the elderly: the Cardiovascular Health Study. Am J Cardiol 1998;82:345-51.
22. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises, part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-7.
23. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37.
24. Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70years of age. Am J Cardiol 2003;92:682-6.
25. Sarnak MJ, Katz R, Stehman-Breen CO, Fried LF, Jenny NS, Psaty BM et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 2005;142:497-505.
26. Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail 2006;12:601-7.
27. Mitsnefes M, Kimbal T, Kartal J, Kathman T, Mishra J, Devarajan P. Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease. Pediatr Nephrol 2006;21:1293-8.
28. Stevens LA, Coresh J, Deysher AE, Feldman HI, Lash JP, Nelson R et al. Evaluation of the MDRD Study equation in a large diverse population. J Am Soc Nephrol 2007;18(10):2749-57.
29. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009;150:604-12.